CL2017001255A1 - Composición de rehidratación oral y los métodos de la misma - Google Patents

Composición de rehidratación oral y los métodos de la misma

Info

Publication number
CL2017001255A1
CL2017001255A1 CL2017001255A CL2017001255A CL2017001255A1 CL 2017001255 A1 CL2017001255 A1 CL 2017001255A1 CL 2017001255 A CL2017001255 A CL 2017001255A CL 2017001255 A CL2017001255 A CL 2017001255A CL 2017001255 A1 CL2017001255 A1 CL 2017001255A1
Authority
CL
Chile
Prior art keywords
oral rehydration
composition
methods
distributional
products
Prior art date
Application number
CL2017001255A
Other languages
English (en)
Spanish (es)
Inventor
Alon Rosenberg
Abraham Milstein
Anthony Mackle
Ava Marie Firth
Monique Michele Schwartz
Dalsem Simon Van
Halpern Arie
Original Assignee
Kalmarna Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54705233&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2017001255(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kalmarna Ltd filed Critical Kalmarna Ltd
Publication of CL2017001255A1 publication Critical patent/CL2017001255A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/02—Acid
    • A23V2250/06—Amino acid
    • A23V2250/0618—Glutamic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/02—Acid
    • A23V2250/06—Amino acid
    • A23V2250/0622—Glycine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/15—Inorganic Compounds
    • A23V2250/156—Mineral combination
    • A23V2250/16—Potassium
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/15—Inorganic Compounds
    • A23V2250/156—Mineral combination
    • A23V2250/1614—Sodium
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/50—Polysaccharides, gums
    • A23V2250/502—Gums
    • A23V2250/5086—Xanthan
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/54—Proteins
    • A23V2250/548—Vegetable protein
    • A23V2250/5482—Cereal protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CL2017001255A 2014-11-19 2017-05-16 Composición de rehidratación oral y los métodos de la misma CL2017001255A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462081588P 2014-11-19 2014-11-19
PCT/IB2015/058699 WO2016079640A1 (en) 2014-11-19 2015-11-11 Oral rehydration composition and methods thereof

Publications (1)

Publication Number Publication Date
CL2017001255A1 true CL2017001255A1 (es) 2018-02-16

Family

ID=54705233

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2017001255A CL2017001255A1 (es) 2014-11-19 2017-05-16 Composición de rehidratación oral y los métodos de la misma

Country Status (25)

Country Link
US (2) US10463067B2 (enExample)
EP (2) EP3685682B1 (enExample)
JP (1) JP6822734B2 (enExample)
KR (1) KR102493948B1 (enExample)
CN (1) CN107205464B (enExample)
AU (1) AU2015347971B2 (enExample)
BR (1) BR112017010483B1 (enExample)
CA (1) CA2968324C (enExample)
CL (1) CL2017001255A1 (enExample)
CO (1) CO2017005016A2 (enExample)
DK (1) DK3220750T3 (enExample)
EA (1) EA033940B1 (enExample)
ES (2) ES2948402T3 (enExample)
HR (2) HRP20200940T1 (enExample)
HU (2) HUE063036T2 (enExample)
MX (2) MX388480B (enExample)
MY (1) MY178335A (enExample)
PE (1) PE20171178A1 (enExample)
PH (1) PH12017500931B1 (enExample)
PL (2) PL3220750T3 (enExample)
PT (1) PT3220750T (enExample)
RS (2) RS60439B1 (enExample)
SI (1) SI3685682T1 (enExample)
WO (1) WO2016079640A1 (enExample)
ZA (1) ZA201703443B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA033940B1 (ru) 2014-11-19 2019-12-11 Калмарна Лимитед Пероральный регидратационный раствор и способ его приготовления
CN111867400A (zh) * 2018-03-15 2020-10-30 潘可士玛股份公司 用于改善哺乳动物健康和行为表现的饲料
DE202018105142U1 (de) * 2018-04-29 2018-10-08 Kalmarna Limited - CCS Trustees Limited Zusammensetzungen zur oralen Verabreichung zum Beeinflussen der Nachkommenschaft von Säugetieren
DE202018105143U1 (de) * 2018-04-29 2018-10-05 Kalmarna Limited - CCS Trustees Limited Zusammensetzungen zum Nähren von Säugetieren
WO2020039443A1 (en) * 2018-08-23 2020-02-27 Kalmarna Limited Compositions and methods for controlling mammalian pathogens
US20200396961A1 (en) * 2019-06-18 2020-12-24 Susu Pets, Llc Container for an aqueous composition
MX2022001281A (es) * 2019-07-29 2022-05-03 Nutreco Ip Assets Bv Composicion de electrolitos y metodos de uso.
CN111035651A (zh) * 2019-12-19 2020-04-21 孙庆 一种改善口感和缓和胃刺激的补钾制剂及其制备
JP7463115B2 (ja) * 2020-01-30 2024-04-08 森永乳業株式会社 電解質補給飲料及びその製造方法
PL242445B1 (pl) * 2020-03-15 2023-02-20 Anwipharma Spolka Z Ograniczona Odpowiedzialnoscia Sposób otrzymywania preparatu i preparat zawierający elektrolity dla zwierząt kopytnych, zwłaszcza koni
WO2022251624A1 (en) * 2021-05-28 2022-12-01 The Coca-Cola Company Amino acid hydration formulation and method of use
IT202200014092A1 (it) * 2022-07-04 2024-01-04 Farm Del Corso Snc Di Ferri Sonia & C Nuova composizione
AU2023321712A1 (en) * 2022-08-11 2025-01-23 Unilever Global Ip Limited Hydration composition
WO2025073885A1 (en) * 2023-10-05 2025-04-10 Aarhus Universitet Composition for use in patients with ileostomy

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2539006A1 (fr) * 1983-01-12 1984-07-13 Agronomique Inst Nat Rech Composition rehydratante utilisable notamment dans l'alimentation de jeunes animaux ne pouvant plus digerer normalement le lait et complement pour sa preparation
GB8512345D0 (en) * 1985-05-15 1985-06-19 Scras Anti-diarrhea compositions
EP0226332B1 (en) * 1985-11-18 1992-03-25 Beecham Group Plc Veterinary compositions
GB9212737D0 (en) 1992-06-16 1992-07-29 Norbrook Lab Veterinary product
US5489440A (en) 1995-03-06 1996-02-06 Abbott Laboratories Rice flour-based oral rehydration solution
GB9609993D0 (en) 1996-05-14 1996-07-17 Norbrook Lab Ltd Oral rehydration product
US7026298B2 (en) * 2001-06-04 2006-04-11 Abbott Laboratories Oral rehydration compositions
US7160565B2 (en) * 2003-03-31 2007-01-09 Breakthru Products, Llc Hydration beverage and method of delivering nutrients
JP4528925B2 (ja) * 2003-05-30 2010-08-25 独立行政法人理化学研究所 アミノ酸組成物及び補液
US8956652B2 (en) * 2005-09-15 2015-02-17 Tower Laboratories, Ltd. Effervescent rehydrating beverage tablet/granules
EP2726083A4 (en) * 2011-07-01 2014-12-17 Drip Drop Inc ORAL REHYDRATION COMPOSITION
US8557301B2 (en) * 2011-07-01 2013-10-15 Drip Drop, Inc. Oral rehydration composition
WO2013133442A1 (ja) * 2012-03-09 2013-09-12 株式会社明治 水分吸収性に優れた飲食品
CN102824362B (zh) * 2012-09-20 2014-03-12 西安安健药业有限公司 一种口服补液盐的药物组合物
CN103479664B (zh) * 2013-09-24 2015-01-07 辽宁亿灵科创生物医药科技有限公司 一种液态口服补液盐
EA033940B1 (ru) 2014-11-19 2019-12-11 Калмарна Лимитед Пероральный регидратационный раствор и способ его приготовления

Also Published As

Publication number Publication date
JP2017535616A (ja) 2017-11-30
AU2015347971B2 (en) 2019-12-19
WO2016079640A1 (en) 2016-05-26
ZA201703443B (en) 2022-03-30
EP3685682C0 (en) 2023-06-07
EP3685682B1 (en) 2023-06-07
CN107205464B (zh) 2020-10-23
BR112017010483A2 (pt) 2018-06-19
HUE063036T2 (hu) 2023-12-28
PT3220750T (pt) 2020-06-25
PE20171178A1 (es) 2017-08-22
US10463067B2 (en) 2019-11-05
MY178335A (en) 2020-10-08
RS60439B1 (sr) 2020-07-31
CA2968324A1 (en) 2016-05-26
JP6822734B2 (ja) 2021-01-27
BR112017010483B1 (pt) 2022-04-05
HUE050306T2 (hu) 2020-11-30
SI3685682T1 (sl) 2023-12-29
EP3220750A1 (en) 2017-09-27
EP3685682A1 (en) 2020-07-29
RS64505B1 (sr) 2023-09-29
CO2017005016A2 (es) 2017-09-11
EA033940B1 (ru) 2019-12-11
HRP20200940T1 (hr) 2020-09-18
PH12017500931A1 (en) 2017-11-20
KR102493948B1 (ko) 2023-01-30
NZ732278A (en) 2024-02-23
MX388480B (es) 2025-03-20
PL3685682T3 (pl) 2023-10-16
EA201791111A1 (ru) 2017-10-31
CN107205464A (zh) 2017-09-26
US20170339997A1 (en) 2017-11-30
DK3220750T3 (da) 2020-06-22
MX2017006475A (es) 2018-05-02
MX2021014983A (es) 2022-02-03
CA2968324C (en) 2023-08-29
US20190059434A1 (en) 2019-02-28
AU2015347971A1 (en) 2017-06-08
ES2799903T3 (es) 2020-12-22
PH12017500931B1 (en) 2017-11-20
ES2948402T3 (es) 2023-09-11
KR20170084317A (ko) 2017-07-19
EP3220750B1 (en) 2020-03-18
HRP20230910T1 (hr) 2023-12-08
PL3220750T3 (pl) 2020-11-02

Similar Documents

Publication Publication Date Title
CL2017001255A1 (es) Composición de rehidratación oral y los métodos de la misma
CY1125424T1 (el) Μη-ανθρωπινα ζωα που εκφραζουν ανθρωποποιημενο cd3 συμπλοκο
DOP2016000295A (es) Compuestos y composiciones como agonistas del receptor tipo toll 7
MX2017006302A (es) Derivados de adenina que son utiles en el tratamiento de enfermedades alergicas u otras afecciones inflamatorias.
MX391171B (es) Anticuerpos anti-cd19 humano con alta afinidad
EA201891202A1 (ru) Композиции, содержащие бактериальные штаммы
MX2016014308A (es) Compuestos y composiciones como agonistas del receptor tipo toll 7.
EA201891201A1 (ru) Композиции, содержащие бактериальные штаммы
EA201890049A1 (ru) Композиции, содержащие бактериальные штаммы
CL2016002394A1 (es) Derivados de quinolina como inhibidores de smo
EP4036099C0 (en) Methods for the preparation of ribosides
CR20140200A (es) Formas solidas de 3-(5-amino-2-metil-4-oxo-ah-quinazolin-3-il)-piperidin-2,6-diona, y sus composiciones farmaceuticas y sus usos
EA201691582A1 (ru) Новые фармацевтические препараты
CL2016000063A1 (es) Nuevos derivados de indolizina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen.
EA201692002A1 (ru) Стабильные составы для антител к cd19 и конъюгатов антитело-лекарственное средство
EA201890097A1 (ru) Индукция регуляторных т-клеток lamina propria
EA201890572A1 (ru) Биофармацевтические композиции
MX2017006167A (es) Compuestos que interactúan con glicanos y métodos de uso.
EA201692526A1 (ru) Замещенные [1,2,4]триазольные соединения
UY36224A (es) Compuestos tricíclicos de imidazo-pirimidinona
CL2018000597A1 (es) Métodos para tratar enfermedades inflamatorias
CO6950477A2 (es) Agentes inductores de la apoptosis que pueden usarse para tratar el cáncer y las enfermedades inmunes y autoinmunes
EA201892568A1 (ru) Способы получения контрастных средств для ультразвукового исследования
BR112017014107A2 (pt) composição nutricional útil no tratamento de pacientes com ibd
MX2016014144A (es) Composiciones de proteina concentrada y metodos para su elaboracion y uso.